Navigation Links
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Date:12/15/2008

alidated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about APD597's development, therapeutic indication, efficacy and potential; the potential of the GDIR, including the potential to stimulate insulin release in response to increases in blood glucose; future activities under Arena's collaboration with Ortho-McNeil; the protocol, design, scope, enrollment and other aspects of the Phase 1 program for APD597; the inclusion of the evaluation of patients with type 2 diabetes in the planned clinical studies; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents an
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... animal health and medical practitioners, announced today that the Company ... , September 4, 2014 – Baird 2014 Healthcare Conference in ... , September 8, 2014 – Morgan Stanley ... NY at 1:25 p.m. ET Henry Schein,s presentations ...
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
(Date:8/21/2014)...  SI-BONE, Inc. ( San Jose, California ... of the iFuse Implant System, ® a minimally ... sacroiliac (SI) joint, announced that Priority Health ( ... Fusion Medical Policy No. 91590-R4 providing positive coverage for ... that the fusion procedure, which employs the iFuse Implant ...
Breaking Medicine Technology:Henry Schein To Present At Two Investor Conferences In September 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... New Mexico Software, Inc. (OTC ... IT services and solutions that enable improved and faster communication ... providing second opinion teleradiology interpretation for its customers. ... for patients and their families who want a second opinion ...
... 2011 Fujitsu , the market ... showcase its network scanning solutions for improved information sharing ... the Annual HIMSS Conference & Exhibition (Booth #5750) in ... network scanners has gained tremendous momentum by helping healthcare ...
Cached Medicine Technology:New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 2New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 3Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 2Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 3
(Date:8/21/2014)... One of the emerging trends that ... is an increasing adoption of non-invasive administration products. As ... patient through their convenient application, they find more preference ... medical device used for the administration of drugs for ... paranasal sinus such as allergic and non-allergic rhinitis and ...
(Date:8/21/2014)... According to a new market report ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... valued at USD 863.1 million in 2013 and is ... 2013 to 2019, to reach an estimated value of ... optics market is witnessing significant growth due to increased ...
(Date:8/21/2014)... It's a terrible thing when a young adult, full ... abuse issue. When that happens to a teenager in Pompano ... help from the qualified substance abuse therapists at a teen ... for those young adults living in Pompano Beach, FL who ... , Thankfully there is a new helpline operating for those ...
(Date:8/21/2014)... Tibet has long been a desired destination ... Prayers flags whip in the wind against the ... of chanting monks fill the otherwise silent temples. ... to Tibet is challenging due to high elevation and ... to be daunting for even the most experienced of ...
(Date:8/21/2014)... 21, 2014 Relias Learning, the leader ... and human services markets, announced the latest release of ... the Tin Can API. , “Supporting the Tin ... the most advanced mobile learning capabilities and the ability ... tools and techniques,” says Jim Triandiflou, CEO of Relias ...
Breaking Medicine News(10 mins):Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 5Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Young Adults in Pompano Beach, FL Are Finding Success With Innovative New Helpline 2Health News:Relias Learning Announces Support for Tin Can API 2
... , PENSACOLA, Fla., Sept. 24 In these ... in preventative healthcare. Better overall health means lower medical bills. ... percent of Americans took two weeks of vacation last year, and ... third in the past generation. The price Americans are paying, by ...
... Irvine, Calif. UC Irvine researchers have created ... of chemotherapeutic drugs to specific cells and organs. ... biophysics, and Richard Robertson, professor of anatomy & ... in diameter) of naturally-occurring lipid molecules, as "packages" ...
... , NEW YORK, Sept. 24 Reportlinker.com ... in its catalogue. , , ... Profiles, Implications for Immunoassays and Molecular Assays) ... , The outbreak of swine flu ...
... , IRVINE, Calif., Sept. 24 ... inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, ... for home care providers, jointly announce a preferred supplier agreement that ... Pulse Oximeters and sensors. Masimo,s solutions are proven to help ...
... ROCHESTER, Minn., Sept. 24 Mayo Clinic,s perspective about how to ... article in the New England Journal of Medicine , ... Oct. 1, 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090105/MAYOLOGO ... other providers accountable for providing high-value health care, defined in terms of ...
... 2009) -- The Weill Cornell Institute of Geriatric ... has received the largest grant in its 20-year ... new $10 million, five-year "Center Grant" from the ... NewYork-Presbyterian/Weill Cornell investigators to advance their pioneering work ...
Cached Medicine News:Health News:Health-Related Tourism Catching On 2Health News:UCI researchers create new strategy for highly-selective chemotherapy delivery 2Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 2Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 3Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 4Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 2Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 3Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 4Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 5Health News:Mayo Clinic Offers Perspective on Health Care Reform in New England Journal of Medicine 2Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 2Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 3Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 4
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits allseven multichannel ... tip cone modules. Both ...
... Pipette is ideal for all liquid handling ... ergonomically-placed operating buttons, and various dispensing techniques ... diluting make this a lab favorite. It ... manual pipette without any adverse effects on ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
Medicine Products: